Navigation Links
Sigma-Aldrich Corporation's 3rd Quarter 2007 Earnings Conference Call
Date:10/5/2007

ST. LOUIS, Oct. 5 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL), will hold its quarterly conference call to discuss third quarter results on Wednesday, October 24, 2007, at 11:00 a.m. Eastern Time (10 a.m. Central Time).

This call is being webcast by Thomson/CCBN and can be accessed at Sigma- Aldrich's Web site at http://www.sigma-aldrich.com.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at http://www.fulldisclosure.com, Thomson/CCBN's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (http://www.streetevents.com).

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 36 countries and has over 7,700 employees providing excellent service worldwide. We are committed to the success of our Customers, Employees and Shareholders through leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit our award-winning web site at http://www.sigma-aldrich.com

Media Contact

Debbie Bockius, 314.286.8015

debbie.bockius@sial.com


'/>"/>
SOURCE Sigma-Aldrich Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Corporations and blogging
2. Midwest life science stocks sizzle in a tepid first quarter
3. CIOs looking to hire more IT workers in second quarter
4. Fiserv posts 30 percent quarterly loss
5. Sonic Foundry reports first cash-positive quarter
6. Venture capital above $6B for third straight quarter
7. Third Wave reports $5.2M third quarter loss
8. Inventions could fall prey to Monday morning quarterbacking
9. Merge fails to file quarterly financial report
10. Rexnord to slash debt after quarterly loss
11. Johnson Controls reports record quarterly sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the ... million people each year. Especially those living in larger cities are affected by air ... one of the most pollution-affected countries globally - decided to take action. , “I ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
(Date:10/10/2017)... SANTA CRUZ, Calif. , Oct. 10, 2017 /PRNewswire/ ... SBIR grant from the NIH to develop RealSeq®-SC (Single ... preparation kit for profiling small RNAs (including microRNAs) from ... Cell Analysis Program highlights the need to accelerate development ... "New techniques for ...
(Date:10/9/2017)... ... October 09, 2017 , ... The award-winning American Farmer television series ... 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , With global population ... challenge of how to continue to feed a growing nation. At the same time, ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
Breaking Biology News(10 mins):